Head-to-head · Value Score
CoreAge Rx vs Pepti
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Pepti a 80. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-namePepti
#65 · Grade B · Good Value
Est. first month
$109 every 28 days, all-in
Save ~92% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 80 — an est. $99/mo first month, with no teaser step-up baked in. Pepti isn't out of it: Shoppers who want a low all-in price with a named pharmacy and named physicians behind it, and who will count thirteen charges a year rather than twelve.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Pepti |
|---|---|---|
| Value Score | 93 (A+) | 80 (B) |
| Est. first month | $99/mo | $109 every 28 days, all-in |
| Save vs brand-name | ~89% | ~92% |
| Semaglutide | $99/mo | $109 every 28 days, all-in |
| Tirzepatide | $149/mo | $179 every 28 days, all-in |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states and D.C. |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Pepti
Compounded semaglutide at $109 and tirzepatide at $179 with the consultation and shipping inside the figure — billed every twenty-eight days, which is thirteen charges a year, on a site whose own cost pages still print two older prices.
Why it's a deal
- The figures are low and genuinely all-in: $109 for compounded semaglutide and $179 for tirzepatide, with the consultation and shipping inside the price rather than added later
- The prices appear on three separate transactable surfaces, which is what makes them checkable rather than a marketing claim on one page
- Coverage is published as a real list — all fifty states and the District of Columbia — rather than as an unqualified nationwide claim
- Two prescribing physicians are named with their specialties, their medical school and their board certifications, and a dispensing partner is named
- The billing terms explain the cycle honestly rather than hiding it: the charge falls on the cycle the supply lasts, measured in days rather than calendar months, and can bill twice in one calendar month
- Cancellation is from the account at any time and stops all future charges, with the one real limit stated: a supply already shipped is not refunded
The fine print
- The cycle is twenty-eight days, so a year is thirteen charges — about $1,417 for semaglutide rather than $1,308, and $2,327 for tirzepatide rather than $2,148 — while the product pages call the figure an all-in monthly price
- The site's own cost pages still print $79 and $149 for the two molecules, on the same pages that describe the price as flat and transparent at $109. Two surfaces disagree with the three that transact
- Labs are conditional rather than included: baseline panels come free only if a doctor requires them, with a deeper panel at $149 and a monthly plan at $129 beside it
- Payment is taken before a physician reviews the intake, and the refund is the remedy; the marketing says only that it is free to start with no enrollment fee
- A money-back badge on the product pages has no matching clause anywhere in the refund policy
- The pharmacy is named but not identified: one partner name with no legal entity, no state and no address, on a page that also says the fulfilling pharmacy varies per patient and that partners may change
- A clearance badge in the homepage trust cluster sits on a site whose product pages correctly say compounded medications are not approved by the FDA, and the badge is never explained
- The corporate address is a shared registered-agent suite rather than a clinical office, and neither named physician publishes an identifier that can be checked against a federal registry
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Pepti.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.